NRSA Training Core
NRSA 培训核心
基本信息
- 批准号:9976619
- 负责人:
- 金额:$ 88.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-21 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AppointmentAwardBiomedical ResearchBiometryCareer ChoiceCategoriesCertificationClinical ResearchClinical SciencesConduct Clinical TrialsDevelopmentDevelopment PlansDisciplineDiscipline of NursingDoctor of PharmacyDoctor of PhilosophyEducational CurriculumEducational workshopElementsEnrollmentEnsureEntrepreneurshipEpidemiologyEthicsEvaluationFosteringFoundationsFutureGrantHealth Insurance Portability and Accountability ActIndividualInstitutesLeadershipManuscriptsMentorsMethodologyNational Research Service AwardsOutcomePathway interactionsPublicationsRecordsResearchResearch DesignResearch PersonnelScienceSolidStudentsTNFSF15 geneTrainingTraining ProgramsTraining and EducationTraining and InfrastructureTranslational ResearchUniversitiesWisconsinWorkforce DevelopmentWritingbasecareercareer developmentclinical investigationexperienceinnovationmembernovelpost-doctoral trainingpre-doctoralprogramsrecruitresponsible research conductskillssuccesstool
项目摘要
Project Summary: The University of Wisconsin (UW) Graduate Program in Clinical Investigation (GPCI) was
developed by the UW Institute for Clinical and Translational Research (ICTR) and continues to be administered
by the ICTR Workforce Development group. GPCI houses multiple educational options for trainees in the
translational research continuum, but all are based on a common didactic foundation encompassing
biostatistics, epidemiology, clinical study design, clinical trials conduct, and the ethical and responsible conduct
of research. These essential curriculum elements are shared by the Certificate in the Fundamentals of Clinical
Research, the MS in Clinical Investigation, and two PhD programs. The PhD in Clinical Investigation is an
applied degree in which trainees focus on the creation of novel methodologies and tools for translational
science within the context of a specific biomedical discipline. The PhD in Clinical and Translational Science
leverages the core curriculum to give trainees the skills and tools necessary to move their biomedical research
along the translational pathway. Since its inception in 2008, GPCI has created a robust infrastructure for
training future members of the translational workforce that has allowed students in the program to accumulate
an impressive record of publications and research awards. For this NRSA application, new leadership has
been appointed distinct from the parental UL1. David DeMets, PhD, and Elizabeth Meyerand, PhD, both have
outstanding training records with mentees at all levels and are exemplary investigators in translational
sciences. Specific aims include maintaining both existing, high-performing PhD programs; applying an
integrated evaluation approach for continuous program improvement and longitudinal outcomes tracking; and
developing recruitment strategies to foster trainee diversity and success. In addition, a new postdoctoral
training program will be created for individuals with professional degrees (MD, DVM, PharmD, Nursing) to
enhance the translational potential of their prior research and provide a bridge to future independent careers in
translational sciences. All trainees will benefit from the existing comprehensive mentoring approach,
development of individualized career development plans (ICDP), and integrated program activities including
federally-mandated training (HIPAA, CITI, GCP, RCR, etc.) and additional training in team science, scientific
leadership, mentor-mentee relationships, and writing manuscripts and grants. GPCI also provides career
development seminars and workshops in innovation and entrepreneurship. The expanded program will support
15 two-year appointments combined in all pre and postdoctoral categories.
项目摘要:威斯康星大学 (UW) 临床研究研究生项目 (GPCI)
由华盛顿大学临床和转化研究所 (ICTR) 开发并继续管理
由卢旺达问题国际法庭劳动力发展小组负责。 GPCI 为学员提供多种教育选择
转化研究的连续体,但所有这些都基于一个共同的教学基础,包括
生物统计学、流行病学、临床研究设计、临床试验实施以及道德和负责任的行为
研究。临床基础证书共享这些基本课程要素
研究、临床研究硕士学位和两个博士学位课程。临床研究博士学位是
应用学位,学员专注于创造新的转化方法和工具
特定生物医学学科背景下的科学。临床和转化科学博士
利用核心课程为学员提供推动生物医学研究所需的技能和工具
沿着翻译途径。自 2008 年成立以来,GPCI 已为以下领域创建了强大的基础设施:
培训翻译劳动力的未来成员,使该计划的学生能够积累经验
令人印象深刻的出版物和研究奖项记录。对于此 NRSA 申请,新领导层已
被任命为与父母 UL1 不同的人。 David DeMets 博士和 Elizabeth Meyerand 博士均拥有
与各级学员的出色培训记录,是翻译领域的模范调查员
科学。具体目标包括维持现有的高性能博士项目;应用一个
用于持续计划改进和纵向结果跟踪的综合评估方法;和
制定招聘策略以促进学员的多样性和成功。此外,还新增一名博士后
将为拥有专业学位(MD、DVM、PharmD、护理)的个人创建培训计划
增强他们先前研究的转化潜力,并为未来的独立职业生涯提供桥梁
转化科学。所有学员都将受益于现有的综合指导方法,
制定个性化职业发展计划(ICDP)和综合计划活动,包括
联邦政府规定的培训(HIPAA、CITI、GCP、RCR 等)以及团队科学、科学
领导力、导师与学员关系以及撰写手稿和资助。 GPCI还提供职业
创新和创业发展研讨会和讲习班。扩展计划将支持
所有博士前和博士后类别共有 15 项两年期任命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark E Burkard其他文献
Mark E Burkard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark E Burkard', 18)}}的其他基金
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10179607 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10381722 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10598560 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10305657 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10527350 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10062906 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
相似海外基金
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
- 批准号:
EP/Z531480/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
- 批准号:
EP/Z531509/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
- 批准号:
EP/Z53156X/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
- 批准号:
EP/Z531625/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
- 批准号:
EP/Z531728/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
- 批准号:
EP/Z531844/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Natural History Museum
2024 年开放访问区块奖 - 自然历史博物馆
- 批准号:
EP/Z531856/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Brighton
2024 年开放获取区块奖 - 布莱顿大学
- 批准号:
EP/Z531935/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bristol
2024 年开放获取区块奖 - 布里斯托大学
- 批准号:
EP/Z531947/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bradford
2024 年开放获取区块奖 - 布拉德福德大学
- 批准号:
EP/Z531923/1 - 财政年份:2024
- 资助金额:
$ 88.61万 - 项目类别:
Research Grant














{{item.name}}会员




